Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALEMBICLTD | NSE
5.59
7.88%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
76.49
72.09
77.08
72.09
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. Alembic Limited was founded in 1907 and is based in Vadodara India. Alembic Limited is a subsidiary of Nirayu Limited.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
77.4%1 month
54.8%3 months
36.5%6 months
30.2%12.29
-
1.57
0.00
0.00
28.46
21.29
-
659.90M
19.71B
211.53M
1.74
35.25
25.40
37.80
12.60
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
11.80
Range1M
20.54
Range3M
34.54
Rel. volume
1.03
Price X volume
27.71M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 298.2 | 21.07B | 1.62% | n/a | 10.48% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 37.2 | 20.55B | 10.45% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 325.3 | 20.30B | 9.88% | n/a | 2.49% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 459.1 | 19.89B | 7.88% | n/a | 107.90% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 159.96 | 19.72B | 8.76% | 69.03 | 68.84% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 187.08 | 17.24B | 14.07% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 767.65 | 16.10B | 4.19% | 35.85 | 0.81% |
| Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 499.5 | 14.45B | 1.19% | 52.36 | 0.60% |
| Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 594.85 | 11.91B | 5.29% | 13.55 | 0.18% |
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1365.6 | 11.62B | 8.46% | 104.15 | 83.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 28.46 | 24.85 | Par |
| Ent. to Revenue | 21.29 | 11.40 | Expensive |
| PE Ratio | 12.29 | 51.36 | Cheaper |
| Price to Book | 1.57 | 6.83 | Cheaper |
| Dividend Yield | 1.74 | 0.52 | Leader |
| Std. Deviation (3M) | 36.51 | 42.17 | Par |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 19.71B | 290.82B | Emerging |